Dexanabinol
- Generic Name
- Dexanabinol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H38O3
- CAS Number
- 112924-45-5
- Unique Ingredient Identifier
- R6VT8U5372
- Indication
Investigated for use/treatment in traumatic brain injuries and neurologic disorders.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
- Conditions
- Interventions
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 112
- Registration Number
- NCT02423239
- Locations
- 🇩🇪
University Hospital Bonn, Study Center Bonn (SZB) Clinical Study Core Unit Institute of Clinical Chemistry and Clinical Pharmacology University Hospital Bonn, Sigmund-Freud-Str. 25, Bonn, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf II. Medizinischen Klinik Martinistr. 52, Hamburg, Germany
🇩🇪Klinikum der Ruhr-Universitaet Bochum, Medizinische Klinik III - Hämatologie/Onkologie Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum Hölkeskampring 40, Herne, Germany
Dexanabinol in Patients With Brain Cancer
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Santosh Kesari, M.D., Ph.D.
- Target Recruit Count
- 26
- Registration Number
- NCT01654497
- Locations
- 🇺🇸
Moores UCSD Cancer Center, La Jolla, California, United States
A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- e-Therapeutics PLC
- Target Recruit Count
- 40
- Registration Number
- NCT01489826
- Locations
- 🇬🇧
Northern Centre for Cancer Care, Freeman Hospital, Newcastle-upon-Tyne, UK, Newcastle-upon-Tyne, Tyne and Wear, United Kingdom
🇬🇧The Beatson West of Scotland Cancer Centre,, Glasgow, United Kingdom
🇬🇧Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
Dexanabinol in Severe Traumatic Brain Injury
- Conditions
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2006-05-05
- Lead Sponsor
- Pharmos
- Target Recruit Count
- 860
- Registration Number
- NCT00129857
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.